This is a Validated Antibody Database (VAD) review about mouse Egln3, based on 4 published articles (read how Labome selects the articles), using Egln3 antibody in all methods. It is aimed to help Labome visitors find the most suited Egln3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Egln3 synonym: 2610021G09Rik; AI505553; AI648162; Hif-p4h-3; Phd3; SM-20

Knockout validation
Invitrogen
domestic rabbit polyclonal
  • western blot knockout validation; human; fig s10a
Invitrogen Egln3 antibody (Invitrogen, PA116526) was used in western blot knockout validation on human samples (fig s10a). Nat Cell Biol (2021) ncbi
Abcam
domestic rabbit monoclonal (EPR17869)
  • western blot; human; 1:1500; loading ...; fig 3a, 6a
Abcam Egln3 antibody (Abcam, ab184714) was used in western blot on human samples at 1:1500 (fig 3a, 6a). J Biomed Sci (2021) ncbi
Novus Biologicals
domestic rabbit polyclonal (6C5cc)
  • western blot; mouse; fig 1
Novus Biologicals Egln3 antibody (Novus, NB100-303) was used in western blot on mouse samples (fig 1). Skelet Muscle (2016) ncbi
domestic rabbit polyclonal (6C5cc)
  • western blot; human; fig 1f
Novus Biologicals Egln3 antibody (Novus Biologicals, NB100-303) was used in western blot on human samples (fig 1f). J Biol Chem (2016) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot knockout validation; human; fig s10a
Invitrogen Egln3 antibody (Invitrogen, PA116526) was used in western blot knockout validation on human samples (fig s10a). Nat Cell Biol (2021) ncbi
Articles Reviewed
  1. Chen W, Song J, Liu S, Tang B, Shen L, Zhu J, et al. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3. J Biomed Sci. 2021;28:44 pubmed publisher
  2. Andrade J, Shi C, Costa A, Choi J, Kim J, Doddaballapur A, et al. Control of endothelial quiescence by FOXO-regulated metabolites. Nat Cell Biol. 2021;23:413-423 pubmed publisher
  3. Shin J, Nunomiya A, Kitajima Y, Dan T, Miyata T, Nagatomi R. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway. Skelet Muscle. 2016;6:5 pubmed publisher
  4. Heir P, Srikumar T, Bikopoulos G, Bunda S, Poon B, Lee J, et al. Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling. J Biol Chem. 2016;291:7357-72 pubmed publisher